About
Treatment of Chronic and Malignant Diseases
Canabolabs is an international pharmaceutical company specializing in the research and development of medicines from natural origin and the development of technologies and patents for medicinal release. The company develops medicine and delivery methods that allow patients who have difficulty using conventional medicine to consume it with ease while maintaining clinical efficiency.
Identity
| Name | Canabolabs |
|---|---|
| Slug | canabolabs |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwIuw3t8JDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jun 2019 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Caesarea |
| HQ address | HaEshel 15, Caesarea, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
medical-cannabispharmaceuticalsbiopharmaceuticaldrug-discoverypharma-companiescannabispain-relief
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}